Australia's most trusted
source of pharma news
Thursday, 07 November 2024
Posted 5 November 2024 AM
Australian scientists have published the results of using gene technology to treat wet age-related macular degeneration and diabetic eye disease, which currently involves receiving injection into the eyeball.
The research, published in the Proceedings of the National Academy of Sciences, outlines how they used an RNA editing tool known as CRISPR Cas13 to suppress the production of Vascular Endothelial Growth Factor (VEGF) in human retinal cells.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.